When does innovation become investable?
If it sounds too good to be true, it probably is.
Today, companies stand on the frontier of enormous technological innovation, but it can be challenging for equity investors to determine which technologies will lead to positive long-term investment returns.
When it comes to evaluating the commercial potential of emerging or evolving technologies such as augmented reality or blockchain, there are a few principles that investors can bear in mind to look beyond the short-term hype.
The first is that it often takes longer for a new technology to make money than is generally expected. This phenomenon is neatly reflected in the Gartner hype cycle, which illustrates how technologies or innovations move from creation, through expectation and disillusionment, to productivity within business over varying timescales which are typically longer than we might expect.
The same can be said of technology companies taking longer than expected to monetise their business models. In February 2018, popular social network Twitter reported its first quarterly profit in 12 years as advertisers have only gradually adopted the platform alongside more established players such as Facebook and Google which account for the bulk of their spending, the Financial Times reports.
The second principle is that once technology does become commercially viable, it can impact far more customers than initially expected. Collaborative robots, for example, which can work alongside human workers on the factory floor, began life in the automotive industry but are now being rapidly deployed across multiple industries like online retail and logistics.
Similarly, while the commercial potential of 3D printing, for example, has not yet been fully realised, the technology has amazing potential for streamlining manufacturing, logistics and sales industries over the coming decades, as it offers companies unique ways of manufacturing bespoke or low volume, high value things such as prototypes or jet engine components.
Tom Riley, research lead for the Automation theme at AXA Investment Managers, says: “We are enthusiastic about 3D printing as a technology, and the market continues to broaden as new materials become available and new productions technologies improve efficiency and capabilities”.
But this optimism for its future applications must be considered alongside the overall volatility of 3D printing market over the last five years, says Riley:
Separating hype from investment reality
So how can equity investors differentiate short-term hype from long-term reality? For Jeremy Gleeson, AXA IM’s research lead for the Connected Consumer, the understanding that most technology innovation typically takes longer than expected to become commercially adopted means that it is important to be lazer-focused.
“We tend to focus where we see meaningful signs of mainstream adoption and commercial adoption of a new technology – that is when our interest picks up,” he says. In terms of identifying these signs of mainstream adoption, Gleeson explains that there are no short cuts, or easy answers.
“We attend lots of trade shows in each of our investment universes, to see how new technologies are being deployed for the first time by companies. This often gives businesses an opportunity to showcase new developments as they come out of R&D facilities for mainstream commercialisation, but more importantly it can serve as a catalyst for us to make investment decisions by talking first-hand to companies and consumers”.
Paying for potential?
Innovative companies can often seem to attract high valuation multiples in the equity markets. Investors can either view these multiples as an expression of shorter-term hype or as the sage identification of growth prospects, but should ultimately consider this alongside longer-term investment horizons. Multiples naturally matter a lot more if you’re thinking on a one-year view, but over a 10-year timeframe, roughly 70% of returns accumulate from revenue growth, according to a study by BCG.
The key to tapping into viable long-term trends, says Mark Hargraves, Head of Global Strategies at Framlington Equities, is a large supply of prudence and patience.
“To deliver sustainable growth outcomes for investors, we focus on the long-term commercial viability and market share of companies’ products or services, by having the patience to wait for innovations to be reflected in company earnings, and by investing only in listed companies with attractive liquidity profiles.”
Not for Retail distribution: This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.
Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 7 Newgate Street, London EC1A 7NX.
In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.